We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+11.19%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$292M
AUM Growth
+$21.1M
Cap. Flow
-$146K
Cap. Flow %
-0.05%
Top 10 Hldgs %
19.9%
Holding
125
New
1
Increased
41
Reduced
17
Closed
1

Top Buys

Rank Stock Value
1
KPTI icon
Karyopharm Therapeutics
KPTI
+$1.88M
2
CORT icon
Corcept Therapeutics
CORT
+$497K
3
BOX icon
Box
BOX
+$406K
4
EDIT icon
Editas Medicine
EDIT
+$328K
5
LOXO
Loxo Oncology, Inc
LOXO
+$308K

Top Sells

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$1.69M
2
NTRA icon
Natera
NTRA
+$1.15M
3
EPAM icon
EPAM Systems
EPAM
+$996K
4
RNG icon
RingCentral
RNG
+$820K
5
PAYC icon
Paycom
PAYC
+$799K

Sector Composition

Rank Sector Weight
1 Technology 25.08%
2 Healthcare 22.23%
3 Communication Services 12.4%
4 Consumer Discretionary 10.65%
5 Financials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPAY icon
51
Corpay
CPAY
$25B
$2.19M 0.75%
9,625
– –
FIZZ icon
52
National Beverage
FIZZ
$2.96B
$2.14M 0.73%
37,494
+2,822
+8% +$158K
EEFT icon
53
Euronet Worldwide
EEFT
$2.72B
$2.13M 0.73%
21,293
+2,311
+12% +$218K
CORT icon
54
Corcept Therapeutics
CORT
$12.4B
$2.1M 0.72%
152,989
+35,550
+30% +$497K
JJSF icon
55
J&J Snack Foods
JJSF
$1.43B
$2.09M 0.72%
14,012
+555
+4% +$82.5K
ISRG icon
56
Intuitive Surgical
ISRG
$127B
$2.08M 0.71%
10,962
– –
SSTK icon
57
Shutterstock
SSTK
$198M
$2.08M 0.71%
39,495
+3,120
+9% +$161K
BOX icon
58
Box
BOX
$4.37B
$2.08M 0.71%
88,174
+16,127
+22% +$406K
SUPN icon
59
Supernus Pharmaceuticals
SUPN
$2.59B
$2.05M 0.7%
41,004
+3,239
+9% +$160K
MC icon
60
Moelis & Co
MC
$4.97B
$2M 0.69%
36,217
+3,968
+12% +$233K
HSTM icon
61
HealthStream
HSTM
$819M
$2M 0.69%
65,365
– –
CSGP icon
62
CoStar Group
CSGP
$11.7B
$1.99M 0.68%
47,680
– –
CAKE icon
63
Cheesecake Factory
CAKE
$5.04B
$1.99M 0.68%
37,118
+2,539
+7% +$137K
PEGA icon
64
Pegasystems
PEGA
$5.02B
$1.99M 0.68%
62,778
-6,246
-9% -$189K
CERN
65
DELISTED
Cerner Corp
CERN
$1.98M 0.68%
30,773
– –
CMG icon
66
Chipotle Mexican Grill
CMG
$47.2B
$1.97M 0.68%
211,750
– –
GBT
67
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.97M 0.67%
51,552
+3,017
+6% +$134K
CRCM
68
DELISTED
CARE.COM, INC.
CRCM
$1.95M 0.67%
89,578
+9,600
+12% +$192K
APTI
69
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$1.94M 0.66%
51,998
– –
TREE icon
70
LendingTree
TREE
$447M
$1.94M 0.66%
8,529
+1,056
+14% +$251K
LMAT icon
71
LeMaitre Vascular
LMAT
$2.32B
$1.93M 0.66%
51,542
– –
FORR icon
72
Forrester Research
FORR
$223M
$1.93M 0.66%
42,002
– –
EVC icon
73
Entravision Communication
EVC
$1.03B
$1.92M 0.66%
387,801
+21,633
+6% +$108K
WTI icon
74
W&T Offshore
WTI
$534M
$1.92M 0.66%
210,951
-46,640
-18% -$338K
CNS icon
75
Cohen & Steers
CNS
$4.23B
$1.89M 0.65%
46,332
+2,491
+6% +$104K
1 2
3
4 5

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Capital Impact Advisors held 125 positions worth $292M, up 7.8% from $270M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 1.6%. Capital Impact Advisors opened 1 new position and exited 1, leaving the 125-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Communication Services.

  • Capital Impact Advisors's largest Q3 2018 buy was Karyopharm Therapeutics: 6,800 shares worth $1.74M.
  • Capital Impact Advisors added most to Corcept Therapeutics in Q3 2018, an estimated $497K increase.
  • Capital Impact Advisors's biggest Q3 2018 reduction was Natera, cutting an estimated $1.15M.
  • Capital Impact Advisors fully exited Super Micro Computer in Q3 2018, selling an estimated $1.69M.
  • Capital Impact Advisors's ten largest holdings make up 20% of its $292M portfolio in Q3 2018.
  • Capital Impact Advisors opened 1 new position and closed 1 in Q3 2018.
  • Capital Impact Advisors's portfolio value rose 7.8% quarter-over-quarter to $292M.

Based on Capital Impact Advisors's 13F filing for Q3 2018, filed 19 Oct 2018.